Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Other solid neoplasm 1

Conditions

Keratosis, Actinic 22Carcinoma, Basal Cell 8Cholangiocarcinoma 7Carcinoma, Non-Small-Cell Lung 7Squamous Cell Carcinoma of Head and Neck 6Skin Neoplasms 4Pancreatic Neoplasms 3Mesothelioma, Malignant 3Lung Neoplasms 3Liver Neoplasms 3Leukoplakia, Oral 3Colorectal Neoplasms 3Bile Duct Neoplasms 3Warts 2Tongue Neoplasms 2Prostatic Neoplasms 2Pleural Diseases 2Neoplasms 2Neoplasm Metastasis 2Mycosis Fungoides 2Esophageal Neoplasms 2Carcinoma, Squamous Cell 2Bowen's Disease 2Basal Cell Nevus Syndrome 2Barrett Esophagus 2Uterine Cervical Neoplasms 1Uterine Cervical Dysplasia 1Thyroid Neoplasms 1Thyroid Cancer, Papillary 1Skin Diseases 1

Interventions

Photochemotherapy 1Drug Therapy 1Dihematoporphyrin Ether 11-phenyl-3,3-dimethyltriazene 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Epitheliod Malignant Pleural Mesothelioma × Photochemotherapy × Clear all
NCT02153229 2025-12-26

MPM-PDT

Abramson Cancer Center at Penn Medicine

Phase 2 Active not recruiting
52 enrolled
Other solid neoplasmThoracic

Epitheliod Malignant Pleural Mesothelioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡